Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174003 · ClinicalTrials.gov registry record
Whole Body Hyperthermia Registry Study
A clinical trial, sponsored by University of Arizona.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02174003 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 2 participants.
The verdict
NCT02174003 was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This protocol will allow for the implementation of a research registry pertaining to Whole Body Hyperthermia (WBH) use in various subject populations. The primary objective of the proposed study is to determine if WBH can have beneficial effects in various subject populations currently experiencing numerous other comorbidities, and the duration of the effect(s). This protocol is intended to become a secondary resort for individual's interested in receiving a Hyperthermia treatment for potential beneficial gain related to symptoms stemming from comorbidities other than depression (i.e. Fibromyalgia, Perimenopausal symptoms, arthritis, etc). Due to the fact that no external research funding has been acquired for this broad application this protocol is intended to charge a fee for cost covering purposes only. The registry trial will not be limited to only include individuals with major depressive disorder, however, this protocol will allow for an expanded use in all populations (while still excluding subjects based on safety parameters). We will monitor subject's physiological and clinical outcomes (if applicable) from a single Whole Body Hyperthermia treatment in an open fashion (no placebo/control condition). This registry study will include safety assessments 5 days prior to WBH, the day of WBH and 1 week following WBH.
Interventions
- DEVICE High intensity whole-body infrared heating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02174003
The ClinicalTrials.gov registry entry for NCT02174003 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High intensity whole-body infrared heating is the first listed.
NCT02174003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02174003 about?
NCT02174003 is a clinical study titled "Whole Body Hyperthermia Registry Study". This protocol will allow for the implementation of a research registry pertaining to Whole Body Hyperthermia (WBH) use in various subject populations. The primary objective of the proposed study is to determine if WBH can have beneficial effects in various subject populations currently experiencing ...
What is the current status of trial NCT02174003?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2014-06. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02174003?
The interventions under investigation include: High intensity whole-body infrared heating (DEVICE).
Who is sponsoring clinical trial NCT02174003?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.